173 related articles for article (PubMed ID: 10826527)
21. Effect of N-methyl-d-aspartate receptor blockade on neuronal plasticity and gastrointestinal transit delay induced by ischemia/reperfusion in rats.
Calcina F; Barocelli E; Bertoni S; Furukawa O; Kaunitz J; Impicciatore M; Sternini C
Neuroscience; 2005; 134(1):39-49. PubMed ID: 15939544
[TBL] [Abstract][Full Text] [Related]
22. [NMDA receptor antagonists in focal cerebral ischemia. An experimental model].
Nathal E; Miquelajauregui JM; Herreman F; Alvarado R; Romero V; Mateos Gomez JH
Gac Med Mex; 1993; 129(2):125-30. PubMed ID: 7926393
[TBL] [Abstract][Full Text] [Related]
23. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.
Nakamura S; Murayama N; Noshita T; Katsuragi R; Ohno T
Eur J Pharmacol; 2006 Oct; 548(1-3):115-22. PubMed ID: 16952349
[TBL] [Abstract][Full Text] [Related]
24. Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia.
Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
J Cereb Blood Flow Metab; 1988 Oct; 8(5):757-62. PubMed ID: 2901425
[TBL] [Abstract][Full Text] [Related]
25. NMDA and AMPA/kainate glutamate receptors modulate dentate neurogenesis and CA3 synapsin-I in normal and ischemic hippocampus.
Bernabeu R; Sharp FR
J Cereb Blood Flow Metab; 2000 Dec; 20(12):1669-80. PubMed ID: 11129783
[TBL] [Abstract][Full Text] [Related]
26. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
Katsuta K; Nakanishi H; Shirakawa K; Yoshida K; Takagi K; Tamura A
J Cereb Blood Flow Metab; 1995 Mar; 15(2):345-8. PubMed ID: 7860668
[TBL] [Abstract][Full Text] [Related]
27. Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats.
Thornton E; Vink R; Blumbergs PC; Van Den Heuvel C
Brain Res; 2006 Jun; 1094(1):38-46. PubMed ID: 16697978
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent effect of S(+) ketamine on post-ischemic endogenous neurogenesis in rats.
Winkelheide U; Lasarzik I; Kaeppel B; Winkler J; Werner C; Kochs E; Engelhard K
Acta Anaesthesiol Scand; 2009 Apr; 53(4):528-33. PubMed ID: 19317867
[TBL] [Abstract][Full Text] [Related]
29. Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats.
O'Connor CA; Cernak I; Johnson F; Vink R
Exp Neurol; 2007 May; 205(1):145-53. PubMed ID: 17362936
[TBL] [Abstract][Full Text] [Related]
30. New method for the quantitative assessment of axonal damage in focal cerebral ischemia.
Imai H; McCulloch J; Graham DI; Masayasu H; Macrae IM
J Cereb Blood Flow Metab; 2002 Sep; 22(9):1080-9. PubMed ID: 12218413
[TBL] [Abstract][Full Text] [Related]
31. [Inefficacy of N-methyl-D-aspartate receptor complex antagonists on behavioral and histologic consequences of global cerebral ischemia in rats].
Allaf R; Vistelle R; Boulu RG
Ann Pharm Fr; 2000 Jul; 58(4):266-70. PubMed ID: 10915975
[TBL] [Abstract][Full Text] [Related]
32. Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improvesoOutcome after brain trauma.
Faden AI; O'Leary DM; Fan L; Bao W; Mullins PG; Movsesyan VA
Exp Neurol; 2001 Feb; 167(2):435-44. PubMed ID: 11161632
[TBL] [Abstract][Full Text] [Related]
33. Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.
Seo SY; Yun BS; Ryoo IJ; Choi JS; Joo CK; Chang SY; Chung JM; Oh S; Gwag BJ; Yoo ID
J Pharmacol Exp Ther; 2001 Oct; 299(1):377-84. PubMed ID: 11561102
[TBL] [Abstract][Full Text] [Related]
34. Comparative effects of the N-methyl-D-aspartate antagonist MK-801 and the calcium channel blocker KB-2796 on neurologic and metabolic recovery after spinal cord ischemia.
Danielisová V; Chavko M
Exp Neurol; 1998 Jan; 149(1):203-8. PubMed ID: 9454629
[TBL] [Abstract][Full Text] [Related]
35. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.
Robinson S; Krentz L; Moore C; Meshul CK
Synapse; 2001 Oct; 42(1):54-61. PubMed ID: 11668591
[TBL] [Abstract][Full Text] [Related]
36. Posthypoxic reoxygenation-induced neurotoxicity prevented by free radical scavenger and NMDA/non-NMDA antagonist in tandem as revealed by dynamic changes in glucose metabolism with positron autoradiography.
Murata T; Omata N; Fujibayashi Y; Waki A; Sadato N; Yoshimoto M; Wada Y; Yonekura Y
Exp Neurol; 2000 Aug; 164(2):269-79. PubMed ID: 10915566
[TBL] [Abstract][Full Text] [Related]
37. Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment.
Ahmed MM; Arif M; Chikuma T; Kato T
Neurochem Int; 2005 Sep; 47(4):248-59. PubMed ID: 15985312
[TBL] [Abstract][Full Text] [Related]
38. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
Faucard R; Armand V; Héron A; Cochois V; Schwartz JC; Arrang JM
J Neurochem; 2006 Sep; 98(5):1487-96. PubMed ID: 16923161
[TBL] [Abstract][Full Text] [Related]
39. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
[TBL] [Abstract][Full Text] [Related]
40. Glutamate receptor antagonists in experimental focal cerebral ischaemia.
McCulloch J; Ozyurt E; Park CK; Nehls DG; Teasdale GM; Graham DI
Acta Neurochir Suppl (Wien); 1993; 57():73-9. PubMed ID: 8421957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
